Terracotta

Same plant, two legal regimes

Hemp is cannabis that tests at or under 0.3% THC. The 2018 Farm Bill made it federally legal, so hemp products — CBD, delta-8, THCA flower, THC beverages — grew into a multi-billion-dollar market sold in smoke shops, gas stations, and online, largely outside licensing systems.

Licensed cannabis ("marijuana") is the state-regulated recreational and medical industry: federally Schedule I, but sold through state-licensed dispensaries by operators who paid heavily for licenses, taxes, and compliance — the multistate operators (MSOs).

The two compete for the same consumer. Hemp sells intoxicating THC without the dispensary's tax and license burden — which is why much of the political spending you'll find on the money page is licensed-cannabis money aimed at restricting hemp.

The chemistry that made the loophole

Raw cannabis flower holds most of its THC as THCA — a non-intoxicating acid that converts to delta-9 THC when heated (decarboxylation). The scientific convention for potency is Total THC = delta-9 + 0.877 × THCA. A flower at 28% THCA and 1.2% delta-9 is "0.3%-compliant hemp" if you measure only delta-9 — and ~25.8% total THC, indistinguishable from dispensary marijuana, the moment it's lit.

What changes November 12, 2026 — in 93 days

§781 of P.L. 119-37 (signed Nov 12, 2025; effective Nov 12, 2026) closes the gap two ways: hemp is redefined by total THC, and finished consumable products are capped at 0.4 mg total THC per container. Synthetic cannabinoids like delta-8 are excluded from the hemp definition entirely.

• Banned federally: THCA flower, delta-8 products, and most THC gummies and beverages — the large majority of today's hemp-cannabinoid market.
• Survives: fiber and grain hemp, and ultra-low-dose CBD/CBG products under 0.4 mg total THC per container.
• Unchanged: the licensed state cannabis system — which is one reason parts of that industry supported the change.

Track the run-up on the 50-state board (many states aren't waiting for the federal date) and the bill tracker.

How this desk scores everything: who does it help?

Because the industries are distinct, "cannabis policy news" is meaningless until you ask which industry wins. Every bill and decision-maker move on this desk is scored on that axis:

• Pro-hemp — protects or expands the hemp market: blocking or delaying bans, reasonable mg caps instead of prohibition, beverage carve-outs, licensing hemp retail rather than criminalizing it.
• Pro-cannabis — advances the licensed industry, often at hemp's expense: hemp restrictions pushed by licensed operators, dispensary-only THC rules, license expansions, state legalization campaigns.
• Both win — lifts both industries: banking access, federal rescheduling or descheduling, interstate commerce, research and safe-harbor rules.
• Both lose — restricts both: blanket THC criminalization, advertising bans, rules that shrink the whole legal market and push demand illicit.
• Mixed — genuinely cuts both ways, or too early to tell.

The running tallies live on the moves page and the front-page scoreboard. The money page shows who is paying for which outcome.

The other armies on the field

The two plant industries aren't the only money in the fight. Three incumbent industries shape these rules from the outside, and the money page tracks their flows alongside the rest:

• Pharma — owns the FDA-approved lane (Jazz bought Epidiolex-maker GW Pharmaceuticals for $7.2B) and has historically funded anti-legalization campaigns — Insys, maker of a fentanyl spray, wrote a $500k check against Arizona's 2016 legalization measure. Rescheduling and CBD rulemaking decide how much of the cannabinoid market ends up behind a prescription.
• Tobacco — Altria put ~$1.8B into Cronos, BAT into Organigram, and Altria + Reynolds founded CPEAR to write the federal legalization framework they'd thrive under. Tobacco wants a consolidated, licensed, nationally-distributed market — which looks a lot more like the cannabis side than open hemp retail.
• Alcohol — Constellation put ~$4B into Canopy, while brewers and distributors fight hemp THC beverages in statehouses (they compete with beer) even as some wholesalers position to distribute them. Alcohol's split personality — invest in it, restrict it — shows up state by state on the bill tracker.

The pattern: big incumbents bet on whichever version of legalization is most licensed, most consolidated, and most distributor-friendly — which usually means the licensed-cannabis side of the ledger, and rarely means open hemp retail.

Why it matters

On the current map, most states are tightening (see the board), the federal definition flips in 93 days, and the documented political money runs overwhelmingly through the licensed-cannabis side. Whether you're an operator, investor, farmer, or regulator, the question that predicts the next twelve months isn't "is cannabis winning" — it's which cannabis industry is winning, where, and who's funding it.

Figures on this page: Total-THC formula and cultivation testing per USDA 7 CFR 990 (2021 Final Rule); §781 provisions per P.L. 119-37 (2025). Not legal advice.